drugset / Trial / NCT05672420
Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies
Phase 1/2
Unknown
181 enrolled
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan Central Hospital · collabWuhan TongJi Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to explore the safety and efficacy of umbilical cord derived mesenchymal stem cells in treatment-induced myelosuppression in patients with hematologic malignancies.
Timeline
- Start
- 2023-01-01
- Primary completion
- 2023-12-31
- Completion
- 2025-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mesenchymal stem cells | Cell therapy | — | Intravenous |